AbstractHere we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.
Biomarkers in lung cancer
CAPPELLANI, Alessandro;
2010-01-01
Abstract
AbstractHere we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
markers in lung cancer.pdf
solo gestori archivio
Dimensione
151.55 kB
Formato
Adobe PDF
|
151.55 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
